General Nutraceutical Technology
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
525 Executive Blvd, Elmsford, New York, ...Website
www.gnt-us.comRevenue
$7.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About General Nutraceutical Technology
GNT is a New York-based start-up biotech company focused on developing novel interventions aimed at improving quality of life and saving lives. The company specializes in the identification, development, and commercialization of therapeutics for allergic and inflammatory diseases, including food allergies, asthma, mast cell activation, allergic rhinitis, eczema, and eosinophilic esophagitis. Their intended clients include individuals suffering from these conditions and healthcare providers seeking effective treatments. GNT's mission underscores their commitment to addressing significant health challenges through innovative solutions.Explore more
Popular SearchesGeneral Nutraceutical Technology LLCSIC Code 87,873NAICS Code 54,541Show more
General Nutraceutical Technology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is General Nutraceutical Technology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if General Nutraceutical Technology is spiking on competitors!
Earning: See what the market has to say on General Nutraceutical Technology recently announced quarterly report
Product Launch: Get notified when General Nutraceutical Technology launches new products
Check if General Nutraceutical Technology has recently received funding, and reach out quickly before it becomes old news!
General Nutraceutical Technology, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at General Nutraceutical Technology
Click to see if General Nutraceutical Technology had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once General Nutraceutical Technology has new funding data
Recommended Actions
Find VP level buyers at General Nutraceutical Technology
Find more new buyers
Compare Similar Companies to General Nutraceutical Technology
Compare insights from companies similar to General Nutraceutical Technology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
1972
TD
Tara DerovanessianClinical Research Assistant & Coordinator & Registered Medical Assistant
Company Profile Activity
Activity Insights
General Nutraceutical Technology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
General Nutraceutical Technology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about General Nutraceutical Technology.
General Nutraceutical Technology Tech Stack
A closer look at the technologies used by General Nutraceutical Technology
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding General Nutraceutical Technology
Sign Up For FreeTo access detailed company insights
GNT is a New York-based start-up biotech company focused on developing novel interventions aimed at improving quality of life and saving lives. The company specializes in the identification, development, and commercialization of therapeutics for allergic and inflammatory diseases, including food allergies, asthma, mast cell activation, allergic rhi... Read More
